Britannia Life Sciences Inc (L020) Stock Statistics & Valuation Metrics
Total Valuation
Britannia Life Sciences Inc has a market cap or net worth of EUR 7.28M. The enterprise value is -EUR 5,988.58.
- Market Cap
- EUR 7.28M
- Enterprise Value
- -EUR 5,988.58
Share Statistics
Britannia Life Sciences Inc has 162,254,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 162,254,330
- Owned by Insiders
- 25.44%
- Owned by Institutions
- ―
Financial Efficiency
Britannia Life Sciences Inc’s return on equity (ROE) is 0.63 and return on invested capital (ROIC) is -6.62%.
- Return on Equity (ROE)
- 0.63
- Return on Assets (ROA)
- 0.55
- Return on Invested Capital (ROIC)
- -6.62%
- Return on Capital Employed (ROCE)
- -0.07
- Revenue Per Employee
- 16.96K
- Profits Per Employee
- 466.93K
- Employee Count
- 28
- Asset Turnover
- 0.02
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Britannia Life Sciences Inc is 0.76. Britannia Life Sciences Inc’s PEG ratio is 0.01.
- PE Ratio
- 0.76
- PS Ratio
- 27.94
- PB Ratio
- 0.52
- Price to FCF
- -17.06
- Price to Operating Cash Flow
- -17.14
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Britannia Life Sciences Inc had revenue of 474.83K and earned 13.07M in profits. Earnings per share was 0.08.
- Revenue
- 474.83K
- Gross Profit
- 38.86K
- Operating Income
- -1.46M
- Pretax Income
- 13.58M
- Net Income
- 13.07M
- EBITDA
- -1.39M
- Earnings Per Share (EPS)
- 0.08
Cash Flow
In the last 12 months, operating cash flow was -665.65K and capital expenditures 4, giving a free cash flow of -665.64K billion.
- Operating Cash Flow
- -665.65K
- Free Cash Flow
- -665.64K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Britannia Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -5.86%
- Earnings Yield
- 144.95%
Stock Price Statistics
- Beta
- -0.75
- 52-Week Price Change
- -31.82%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- 71.89
- Average Volume (3m)
- ―
Important Dates
Britannia Life Sciences Inc upcoming earnings date is Nov 26, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Nov 26, 2026
- Ex-Dividend Date
- ―
Financial Position
Britannia Life Sciences Inc as a current ratio of 6.57, with Debt / Equity ratio of 1.10%
- Current Ratio
- 6.57
- Quick Ratio
- 6.57
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.79
- Interest Coverage Ratio
- -57.36
Taxes
In the past 12 months, Britannia Life Sciences Inc has paid 507.84K in taxes.
- Income Tax
- 507.84K
- Effective Tax Rate
- 0.04
Enterprise Valuation
Britannia Life Sciences Inc EV to EBITDA ratio is 0.25, with an EV/FCF ratio of 0.40.
- EV to Sales
- -0.66
- EV to EBITDA
- 0.25
- EV to Free Cash Flow
- 0.40
- EV to Operating Cash Flow
- 0.40
Balance Sheet
Britannia Life Sciences Inc has EUR 12.41M in cash and marketable securities with EUR 211.52K in debt, giving a net cash position of EUR 12.20M billion.
- Cash & Marketable Securities
- EUR 12.41M
- Total Debt
- EUR 211.52K
- Net Cash
- EUR 12.20M
- Net Cash Per Share
- EUR 0.08
- Tangible Book Value Per Share
- EUR 0.14
Margins
Gross margin is 7.38%, with operating margin of -356.68%, and net profit margin of 4069.61%.
- Gross Margin
- 7.38%
- Operating Margin
- -356.68%
- Pretax Margin
- 3806.56%
- Net Profit Margin
- 4069.61%
- EBITDA Margin
- -263.10%
- EBIT Margin
- -278.59%
